Table of Content

Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Reduced mortality rate
3.4.1.2. Technological advancements in TAVR embolic protection devices
3.4.1.3. Growing adoption of minimally invasive procedures
3.4.2. Restraints
3.4.2.1. Product failure and recalls
3.4.2.2. Procedural Complexity
3.4.3. Opportunities
3.4.3.1. Growing focus on Research and development
Chapter 4: TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. SENTINEL cerebral protection system
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. TriGUARD 3 CEP device technology
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
Chapter 5: TAVR EMBOLIC PROTECTION MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast By Region
5.2. North America
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by Product
5.2.3. Market size and forecast, by country
5.2.3.1. U.S.
5.2.3.1.1. Market size and forecast, by Product
5.2.3.2. Canada
5.2.3.2.1. Market size and forecast, by Product
5.3. Europe
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by Product
5.3.3. Market size and forecast, by country
5.3.3.1. Germany
5.3.3.1.1. Market size and forecast, by Product
5.3.3.2. France
5.3.3.2.1. Market size and forecast, by Product
5.3.3.3. UK
5.3.3.3.1. Market size and forecast, by Product
5.3.3.4. Italy
5.3.3.4.1. Market size and forecast, by Product
5.3.3.5. Rest of Europe
5.3.3.5.1. Market size and forecast, by Product
5.4. Asia-Pacific
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by Product
5.4.3. Market size and forecast, by country
5.4.3.1. Japan
5.4.3.1.1. Market size and forecast, by Product
5.4.3.2. China
5.4.3.2.1. Market size and forecast, by Product
5.4.3.3. India
5.4.3.3.1. Market size and forecast, by Product
5.4.3.4. Australia
5.4.3.4.1. Market size and forecast, by Product
5.4.3.5. Rest of Asia-Pacific
5.4.3.5.1. Market size and forecast, by Product
5.5. LAMEA
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by Product
5.5.3. Market size and forecast, by country
5.5.3.1. Latin America
5.5.3.1.1. Market size and forecast, by Product
5.5.3.2. Middle East And Africa
5.5.3.2.1. Market size and forecast, by Product
Chapter 6: COMPETITIVE LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product mapping of top 10 player
6.4. Competitive dashboard
6.5. Competitive heatmap
6.6. Top player positioning, 2022
Chapter 7: COMPANY PROFILES
7.1. Boston Scientific Corporation
7.1.1. Company overview
7.1.2. Key executives
7.1.3. Company snapshot
7.1.4. Operating business segments
7.1.5. Product portfolio
7.1.6. Business performance
7.2. Edward Lifesciences Corporation
7.2.1. Company overview
7.2.2. Key executives
7.2.3. Company snapshot
7.2.4. Operating business segments
7.2.5. Product portfolio
7.2.6. Business performance
7.3. Filterlex Medical Ltd.
7.3.1. Company overview
7.3.2. Key executives
7.3.3. Company snapshot
7.3.4. Operating business segments
7.3.5. Product portfolio
7.3.6. Key strategic moves and developments
7.4. Protembis GmbH
7.4.1. Company overview
7.4.2. Key executives
7.4.3. Company snapshot
7.4.4. Operating business segments
7.4.5. Product portfolio
7.4.6. Key strategic moves and developments
7.5. Innovative Cardiovascular Solutions, LLC.
7.5.1. Company overview
7.5.2. Key executives
7.5.3. Company snapshot
7.5.4. Operating business segments
7.5.5. Product portfolio
7.6. EnCompass Technologies, Inc.
7.6.1. Company overview
7.6.2. Key executives
7.6.3. Company snapshot
7.6.4. Operating business segments
7.6.5. Product portfolio
7.6.6. Key strategic moves and developments
7.7. Transverse Medical Inc.
7.7.1. Company overview
7.7.2. Key executives
7.7.3. Company snapshot
7.7.4. Operating business segments
7.7.5. Product portfolio
7.8. Emboline, Inc.
7.8.1. Company overview
7.8.2. Key executives
7.8.3. Company snapshot
7.8.4. Operating business segments
7.8.5. Product portfolio
7.8.6. Key strategic moves and developments
7.9. Cardioptimus
7.9.1. Company overview
7.9.2. Key executives
7.9.3. Company snapshot
7.9.4. Operating business segments
7.9.5. Product portfolio
7.10. Venus MedTech HangZhou Inc.
7.10.1. Company overview
7.10.2. Key executives
7.10.3. Company snapshot
7.10.4. Operating business segments
7.10.5. Product portfolio
7.10.6. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. TAVR EMBOLIC PROTECTION MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF TAVR EMBOLIC PROTECTION MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN TAVR EMBOLIC PROTECTION MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN TAVR EMBOLIC PROTECTION MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL TAVR EMBOLIC PROTECTION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TAVR EMBOLIC PROTECTION MARKET FOR SENTINEL CEREBRAL PROTECTION SYSTEM, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TAVR EMBOLIC PROTECTION MARKET FOR TRIGUARD 3 CEP DEVICE TECHNOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. TAVR EMBOLIC PROTECTION MARKET BY REGION, 2022 AND 2032(%)
FIGURE 15. U.S. TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 16. CANADA TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 17. GERMANY TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 18. FRANCE TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 19. UK TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 20. ITALY TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 21. REST OF EUROPE TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 22. JAPAN TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 23. CHINA TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 24. INDIA TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 25. AUSTRALIA TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 26. REST OF ASIA-PACIFIC TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 27. LATIN AMERICA TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 28. MIDDLE EAST AND AFRICA TAVR EMBOLIC PROTECTION MARKET, 2022-2032 ($THOUSAND)
FIGURE 29. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
FIGURE 30. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
FIGURE 31. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
FIGURE 32. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 33. COMPETITIVE DASHBOARD
FIGURE 34. COMPETITIVE HEATMAP: TAVR EMBOLIC PROTECTION MARKET
FIGURE 35. TOP PLAYER POSITIONING, 2022
FIGURE 36. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 38. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 39. EDWARD LIFESCIENCES CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 40. EDWARD LIFESCIENCES CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 41. EDWARD LIFESCIENCES CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. GLOBAL TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 02. TAVR EMBOLIC PROTECTION MARKET FOR SENTINEL CEREBRAL PROTECTION SYSTEM, BY REGION, 2022-2032 ($THOUSAND)
TABLE 03. TAVR EMBOLIC PROTECTION MARKET FOR TRIGUARD 3 CEP DEVICE TECHNOLOGY, BY REGION, 2022-2032 ($THOUSAND)
TABLE 04. TAVR EMBOLIC PROTECTION MARKET, BY REGION, 2022-2032 ($THOUSAND)
TABLE 05. NORTH AMERICA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 06. NORTH AMERICA TAVR EMBOLIC PROTECTION MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 07. U.S. TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 08. CANADA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 09. EUROPE TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 10. EUROPE TAVR EMBOLIC PROTECTION MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 11. GERMANY TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 12. FRANCE TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 13. UK TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 14. ITALY TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 15. REST OF EUROPE TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 16. ASIA-PACIFIC TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 17. ASIA-PACIFIC TAVR EMBOLIC PROTECTION MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 18. JAPAN TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 19. CHINA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 20. INDIA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 21. AUSTRALIA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 22. REST OF ASIA-PACIFIC TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 23. LAMEA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 24. LAMEA TAVR EMBOLIC PROTECTION MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
TABLE 25. LATIN AMERICA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 26. MIDDLE EAST AND AFRICA TAVR EMBOLIC PROTECTION MARKET, BY PRODUCT, 2022-2032 ($THOUSAND)
TABLE 27. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 28. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 29. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 30. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 31. EDWARD LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 32. EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 33. EDWARD LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
TABLE 34. EDWARD LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 35. FILTERLEX MEDICAL LTD.: KEY EXECUTIVES
TABLE 36. FILTERLEX MEDICAL LTD.: COMPANY SNAPSHOT
TABLE 37. FILTERLEX MEDICAL LTD.: PRODUCT SEGMENTS
TABLE 38. FILTERLEX MEDICAL LTD.: PRODUCT PORTFOLIO
TABLE 39. FILTERLEX MEDICAL LTD.: KEY STRATERGIES
TABLE 40. PROTEMBIS GMBH: KEY EXECUTIVES
TABLE 41. PROTEMBIS GMBH: COMPANY SNAPSHOT
TABLE 42. PROTEMBIS GMBH: PRODUCT SEGMENTS
TABLE 43. PROTEMBIS GMBH: PRODUCT PORTFOLIO
TABLE 44. PROTEMBIS GMBH: KEY STRATERGIES
TABLE 45. INNOVATIVE CARDIOVASCULAR SOLUTIONS, LLC.: KEY EXECUTIVES
TABLE 46. INNOVATIVE CARDIOVASCULAR SOLUTIONS, LLC.: COMPANY SNAPSHOT
TABLE 47. INNOVATIVE CARDIOVASCULAR SOLUTIONS, LLC.: PRODUCT SEGMENTS
TABLE 48. INNOVATIVE CARDIOVASCULAR SOLUTIONS, LLC.: PRODUCT PORTFOLIO
TABLE 49. ENCOMPASS TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 50. ENCOMPASS TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 51. ENCOMPASS TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 52. ENCOMPASS TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 53. ENCOMPASS TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 54. TRANSVERSE MEDICAL INC.: KEY EXECUTIVES
TABLE 55. TRANSVERSE MEDICAL INC.: COMPANY SNAPSHOT
TABLE 56. TRANSVERSE MEDICAL INC.: PRODUCT SEGMENTS
TABLE 57. TRANSVERSE MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 58. EMBOLINE, INC.: KEY EXECUTIVES
TABLE 59. EMBOLINE, INC.: COMPANY SNAPSHOT
TABLE 60. EMBOLINE, INC.: PRODUCT SEGMENTS
TABLE 61. EMBOLINE, INC.: PRODUCT PORTFOLIO
TABLE 62. EMBOLINE, INC.: KEY STRATERGIES
TABLE 63. CARDIOPTIMUS: KEY EXECUTIVES
TABLE 64. CARDIOPTIMUS: COMPANY SNAPSHOT
TABLE 65. CARDIOPTIMUS: PRODUCT SEGMENTS
TABLE 66. CARDIOPTIMUS: PRODUCT PORTFOLIO
TABLE 67. VENUS MEDTECH HANGZHOU INC.: KEY EXECUTIVES
TABLE 68. VENUS MEDTECH HANGZHOU INC.: COMPANY SNAPSHOT
TABLE 69. VENUS MEDTECH HANGZHOU INC.: PRODUCT SEGMENTS
TABLE 70. VENUS MEDTECH HANGZHOU INC.: PRODUCT PORTFOLIO
TABLE 71. VENUS MEDTECH HANGZHOU INC.: KEY STRATERGIES